tiprankstipranks
Trending News
More News >
Sprint Bioscience AB (DE:5JA1)
:5JA1
Germany Market

Sprint Bioscience AB (5JA1) Financial Statements

Compare
0 Followers

Sprint Bioscience AB Financial Overview

Sprint Bioscience AB's market cap is currently €4.18M. The company's EPS TTM is €-0.007289360000000001; its P/E ratio is ―; Sprint Bioscience AB is scheduled to report earnings on May 27, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 65.64Mkr 50.48Mkr 83.00Kkr 35.11Mkr 16.89M
Gross Profitkr 37.30Mkr 41.79Mkr -60.91Mkr 24.68Mkr 6.43M
Operating Incomekr -19.67Mkr -845.00Kkr -60.91Mkr -25.47Mkr -37.67M
EBITDAkr -17.32Mkr -2.08Mkr -60.00Mkr -24.49Mkr -38.05M
Net Incomekr -18.28Mkr -438.00Kkr -60.17Mkr -25.35Mkr -46.23M
Balance Sheet
Cash & Short-Term Investmentskr 25.06Mkr 49.93Mkr 29.49Mkr 70.64Mkr 27.07M
Total Assetskr 42.05Mkr 62.38Mkr 37.42Mkr 79.14Mkr 33.40M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 10.00M
Net Debtkr -25.06Mkr -49.93Mkr -29.49Mkr -70.64Mkr -17.07M
Total Liabilitieskr 32.78Mkr 34.60Mkr 9.23Mkr 8.68Mkr 24.25M
Stockholders' Equitykr 9.27Mkr 27.77Mkr 28.19Mkr 70.45Mkr 9.14M
Cash Flow
Free Cash Flowkr -24.65Mkr 20.42Mkr -59.05Mkr -42.82Mkr -32.22M
Operating Cash Flowkr -23.36Mkr 22.87Mkr -59.05Mkr -40.12Mkr -32.22M
Investing Cash Flowkr -1.30Mkr -2.45Mkr 0.00kr -2.71Mkr 0.00
Financing Cash Flowkr -225.00Kkr 24.00Kkr 17.90Mkr 86.39Mkr 50.92M
Currency in SEK

Sprint Bioscience AB Earnings and Revenue History

Sprint Bioscience AB Debt to Assets

Sprint Bioscience AB Cash Flow

Sprint Bioscience AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis